Biology of Vascular Malformations of the Brain

Background and Purpose— This review discusses recent research on the genetic, molecular, cellular, and developmental mechanisms underlying the etiology of vascular malformations of the brain (VMBs), including cerebral cavernous malformation, sporadic brain arteriovenous malformation, and the arteriovenous malformations of hereditary hemorrhagic telangiectasia. Summary of Review— The identification of gene mutations and genetic risk factors associated with cerebral cavernous malformation, hereditary hemorrhagic telangiectasia, and sporadic arteriovenous malformation has enabled the development of animal models for these diseases and provided new insights into their etiology. All of the genes associated with VMBs to date have known or plausible roles in angiogenesis and vascular remodeling. Recent work suggests that the angiogenic process most severely disrupted by VMB gene mutation is that of vascular stabilization, the process whereby vascular endothelial cells form capillary tubes, strengthen their intercellular junctions, and recruit smooth muscle cells to the vessel wall. In addition, there is now good evidence that in some cases, cerebral cavernous malformation lesion formation involves a genetic 2-hit mechanism in which a germline mutation in one copy of a cerebral cavernous malformation gene is followed by a somatic mutation in the other copy. There is also increasing evidence that environmental second hits can produce lesions when there is a mutation to a single allele of a VMB gene. Conclusions— Recent findings begin to explain how mutations in VMB genes render vessels vulnerable to rupture when challenged with other inauspicious genetic or environmental factors and have suggested candidate therapeutics. Understanding of the cellular mechanisms of VMB formation and progression in humans has lagged behind that in animal models. New knowledge of lesion biology will spur new translational work. Several well-established clinical and genetic database efforts are already in place, and further progress will be facilitated by collaborative expansion and standardization of these.

[1]  J. Gault,et al.  CEREBRAL CAVERNOUS MALFORMATIONS: SOMATIC MUTATIONS IN VASCULAR ENDOTHELIAL CELLS , 2009, Neurosurgery.

[2]  U. Felbor,et al.  Functional analyses of human and zebrafish 18–amino acid in‐frame deletion pave the way for domain mapping of the cerebral cavernous malformation 3 protein , 2009, Human Mutation.

[3]  N. Sciaky,et al.  Cerebral Cavernous Malformation 2 Protein Promotes Smad Ubiquitin Regulatory Factor 1-mediated RhoA Degradation in Endothelial Cells , 2009, Journal of Biological Chemistry.

[4]  Shawn M. Sweeney,et al.  Erratum: Regulation of cardiovascular development and integrity by the heart of glass- cerebral cavernous malformation protein pathway (Natural Medical (2007) 15 (169-176)) , 2009 .

[5]  N. Petit,et al.  Tissue-specific conditional CCM2 knockout mice establish the essential role of endothelial CCM2 in angiogenesis: implications for human cerebral cavernous malformations , 2009, Disease Models & Mechanisms.

[6]  G. Steinberg,et al.  Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. , 2009, Human molecular genetics.

[7]  Christopher A. Jones,et al.  The Cerebral Cavernous Malformation signaling pathway promotes vascular integrity via Rho GTPases , 2009, Nature Medicine.

[8]  C. McCulloch,et al.  Common Variants in Interleukin-1-Beta Gene Are Associated with Intracranial Hemorrhage and Susceptibility to Brain Arteriovenous Malformation , 2008, Cerebrovascular Diseases.

[9]  U. Felbor,et al.  A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells , 2008, Human molecular genetics.

[10]  W. Young,et al.  Increased tissue perfusion promotes capillary dysplasia in the ALK1-deficient mouse brain following VEGF stimulation. , 2008, American journal of physiology. Heart and circulatory physiology.

[11]  P. Rothwell,et al.  Outcome after spontaneous and arteriovenous malformation-related intracerebral haemorrhage: population-based studies. , 2008, Brain : a journal of neurology.

[12]  L. Morrison,et al.  Hemorrhage From Cavernous Malformations of the Brain: Definition and Reporting Standards , 2008, Stroke.

[13]  R. Shenkar,et al.  ADVANCED MAGNETIC RESONANCE IMAGING OF CEREBRAL CAVERNOUS MALFORMATIONS: PART II. IMAGING OF LESIONS IN MURINE MODELS , 2008, Neurosurgery.

[14]  H. Wolburg,et al.  ccm1 cell autonomously regulates endothelial cellular morphogenesis and vascular tubulogenesis in zebrafish. , 2008, Human molecular genetics.

[15]  Tyson N. Kim,et al.  Endothelial Notch4 signaling induces hallmarks of brain arteriovenous malformations in mice , 2008, Proceedings of the National Academy of Sciences.

[16]  N. Barbaro,et al.  EVIDENCE OF INFLAMMATORY CELL INVOLVEMENT IN BRAIN ARTERIOVENOUS MALFORMATIONS , 2008, Neurosurgery.

[17]  Christopher C W Hughes,et al.  TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotype. , 2008, Blood.

[18]  C. Warlow,et al.  Outcome after interventional or conservative management of unruptured brain arteriovenous malformations: a prospective, population-based cohort study , 2008, The Lancet Neurology.

[19]  Marie-José Goumans,et al.  Endoglin in angiogenesis and vascular diseases , 2008, Angiogenesis.

[20]  H. Augustin,et al.  Flow‐dependent regulation of angiopoietin‐2 , 2008, Journal of cellular physiology.

[21]  C. McCulloch,et al.  Feasibility of Minocycline and Doxycycline Use as Potential Vasculostatic Therapy for Brain Vascular Malformations: Pilot Study of Adverse Events and Tolerance , 2008, Cerebrovascular Diseases.

[22]  V. Kaartinen,et al.  ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2. , 2008, Blood.

[23]  Bernhard Schmierer,et al.  TGFβ–SMAD signal transduction: molecular specificity and functional flexibility , 2007, Nature Reviews Molecular Cell Biology.

[24]  R. Shenkar,et al.  Oligoclonal immune response in cerebral cavernous malformations. Laboratory investigation. , 2007, Journal of neurosurgery.

[25]  M. Ginsberg,et al.  KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell–cell junctions , 2007, The Journal of cell biology.

[26]  T. Haystead,et al.  Proteomic identification of the cerebral cavernous malformation signaling complex. , 2007, Journal of proteome research.

[27]  C. McCulloch,et al.  Racial/Ethnic Differences in Longitudinal Risk of Intracranial Hemorrhage in Brain Arteriovenous Malformation Patients , 2007, Stroke.

[28]  Patrick W. Faloon,et al.  A βPix–Pak2a signaling pathway regulates cerebral vascular stability in zebrafish , 2007, Proceedings of the National Academy of Sciences.

[29]  Julio D Amigo,et al.  pak2a mutations cause cerebral hemorrhage in redhead zebrafish , 2007, Proceedings of the National Academy of Sciences.

[30]  Wenlong Li,et al.  Essential Role of Endothelial Smad4 in Vascular Remodeling and Integrity , 2007, Molecular and Cellular Biology.

[31]  Xiao Han,et al.  PDCD10 interacts with Ste20-related kinase MST4 to promote cell growth and transformation via modulation of the ERK pathway. , 2007, Molecular biology of the cell.

[32]  Ling Wei,et al.  Whisker Stimulation Enhances Angiogenesis in the Barrel Cortex following Focal Ischemia in Mice , 2007 .

[33]  M. Lawton,et al.  Growth and regression of arteriovenous malformations in a patient with hereditary hemorrhagic telangiectasia. Case report. , 2007, Journal of neurosurgery.

[34]  Ling Wei,et al.  Whisker Stimulation Enhances Angiogenesis in the Barrel Cortex following Focal Ischemia in Mice , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[35]  M. Goumans,et al.  Endoglin Has a Crucial Role in Blood Cell–Mediated Vascular Repair , 2006, Circulation.

[36]  G. Davis,et al.  Coregulation of vascular tube stabilization by endothelial cell TIMP-2 and pericyte TIMP-3 , 2006, The Journal of cell biology.

[37]  Yiqian Zhu,et al.  Expression of Hypoxia-inducible Factor-1 and Vascular Endothelial Growth Factor in Response to Venous Hypertension , 2006, Neurosurgery.

[38]  N. Petit,et al.  Patterns of expression of the three cerebral cavernous malformation (CCM) genes during embryonic and postnatal brain development. , 2006, Gene expression patterns : GEP.

[39]  W. Young,et al.  Intracranial aneurysms: links among inflammation, hemodynamics and vascular remodeling , 2006, Neurological research.

[40]  M. Morgan,et al.  Ultrastructure of Perinidal Capillaries in Cerebral Arteriovenous Malformations , 2006, Neurosurgery.

[41]  R. Pyeritz,et al.  SMAD4 mutations found in unselected HHT patients , 2006, Journal of Medical Genetics.

[42]  H. Matsunami,et al.  Neuronal expression of the Ccm2 gene in a new mouse model of cerebral cavernous malformations , 2006, Mammalian Genome.

[43]  J. LaManna,et al.  Chronic hypoxia and the cerebral circulation. , 2006, Journal of applied physiology.

[44]  R. Adams,et al.  Ephrin-B2 Controls Cell Motility and Adhesion during Blood-Vessel-Wall Assembly , 2006, Cell.

[45]  Pui-Yan Kwok,et al.  Tumor Necrosis Factor-&agr;–238G>A Promoter Polymorphism Is Associated With Increased Risk of New Hemorrhage in the Natural Course of Patients With Brain Arteriovenous Malformations , 2006 .

[46]  K. Jin,et al.  From angiogenesis to neuropathology , 2005, Nature.

[47]  M. Morgan,et al.  Ultrastructural characteristics of hemorrhagic, nonhemorrhagic, and recurrent cavernous malformations. , 2005, Journal of neurosurgery.

[48]  C. McCulloch,et al.  Polymorphisms in Transforming Growth Factor-β-Related Genes ALK1 and ENG Are Associated With Sporadic Brain Arteriovenous Malformations , 2005, Stroke.

[49]  K. Plate,et al.  The Role of Angiopoietins During Angiogenesis in Gliomas , 2005, Brain pathology.

[50]  C. Betsholtz,et al.  Endothelial/Pericyte Interactions , 2005, Circulation research.

[51]  N. Barbaro,et al.  Coexpression of Angiogenic Factors in Brain Arteriovenous Malformations , 2005, Neurosurgery.

[52]  J. Gault,et al.  Biallelic Somatic and Germ Line CCM1 Truncating Mutations in a Cerebral Cavernous Malformation Lesion , 2005, Stroke.

[53]  L. McCullough,et al.  Estradiol Regulates Angiopoietin-1 mRNA Expression Through Estrogen Receptor-&agr; in a Rodent Experimental Stroke Model , 2005, Stroke.

[54]  D. Louis,et al.  Loss of p53 sensitizes mice with a mutation in Ccm1 (KRIT1) to development of cerebral vascular malformations. , 2004, The American journal of pathology.

[55]  C. McCulloch,et al.  Polymorphisms in Genes Involved in Inflammatory and Angiogenic Pathways and the Risk of Hemorrhagic Presentation of Brain Arteriovenous Malformations , 2004, Stroke.

[56]  J. Gault,et al.  Pathobiology of human cerebrovascular malformations: basic mechanisms and clinical relevance. , 2004, Neurosurgery.

[57]  W. Young,et al.  Vascular Endothelial Growth Factor Induces Abnormal Microvasculature in the Endoglin Heterozygous Mouse Brain , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[58]  M. Matsumoto,et al.  Perinidal Dilated Capillary Networks in Cerebral Arteriovenous Malformations , 2004, Neurosurgery.

[59]  M. Dell'Acqua,et al.  Rac–MEKK3–MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock , 2003, Nature Cell Biology.

[60]  R. Fodde,et al.  Of mice and (wo)men: genotype-phenotype correlations in BRCA1. , 2003, Human molecular genetics.

[61]  T. Seki,et al.  Arterial Endothelium-Specific Activin Receptor-Like Kinase 1 Expression Suggests Its Role in Arterialization and Vascular Remodeling , 2003, Circulation research.

[62]  Y. Ha,et al.  Reinduced expression of developmental proteins (nestin, small heat shock protein) in and around cerebral arteriovenous malformations. , 2003, Clinical neuropathology.

[63]  Dean Y. Li,et al.  Loss of distinct arterial and venous boundaries in mice lacking endoglin, a vascular-specific TGFbeta coreceptor. , 2003, Developmental biology.

[64]  J Pile-Spellman,et al.  The New York Islands AVM Study: Design, Study Progress, and Initial Results , 2003, Stroke.

[65]  C. Warlow,et al.  Prospective, Population-Based Detection of Intracranial Vascular Malformations in Adults: The Scottish Intracranial Vascular Malformation Study (SIVMS) , 2003, Stroke.

[66]  D. Marchuk,et al.  Vascular morphogenesis: tales of two syndromes. , 2003, Human molecular genetics.

[67]  J. Soames,et al.  Mouse Model for Hereditary Hemorrhagic Telangiectasia Has a Generalized Vascular Abnormality , 2003, Circulation.

[68]  M. Porteous,et al.  A mouse model for hereditary hemorrhagic telangiectasia (HHT) type 2. , 2003, Human molecular genetics.

[69]  A. Paterson,et al.  Cerebral Vascular Abnormalities in a Murine Model of Hereditary Hemorrhagic Telangiectasia , 2003, Stroke.

[70]  Steven A. Goldman,et al.  Coordinated Interaction of Neurogenesis and Angiogenesis in the Adult Songbird Brain , 2002, Neuron.

[71]  B. Crain,et al.  Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations , 2001, Journal of neurology, neurosurgery, and psychiatry.

[72]  M. Tarnawski,et al.  Immunogold study of interendothelial junction-associated and glucose transporter proteins during postnatal maturation of the mouse blood-brain barrier , 2001, Journal of neurocytology.

[73]  M. Lawton,et al.  Evidence of Increased Endothelial Cell Turnover in Brain Arteriovenous Malformations , 2001, Neurosurgery.

[74]  A. Siegel,et al.  Endothelial proliferation, neoangiogenesis, and potential de novo generation of cerebrovascular malformations. , 2001, Journal of neurosurgery.

[75]  H. Etchevers,et al.  The cephalic neural crest provides pericytes and smooth muscle cells to all blood vessels of the face and forebrain. , 2001, Development.

[76]  M. Labinaz,et al.  Endoglin Is Overexpressed After Arterial Injury and Is Required for Transforming Growth Factor-&bgr;–Induced Inhibition of Smooth Muscle Cell Migration , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[77]  R. Clatterbuck,et al.  Dynamic nature of cavernous malformations: a prospective magnetic resonance imaging study with volumetric analysis. , 2000, Journal of neurosurgery.

[78]  Dean Y. Li,et al.  Arteriovenous malformations in mice lacking activin receptor-like kinase-1 , 2000, Nature Genetics.

[79]  G. Knott,et al.  Barriers in the Immature Brain , 2000, Cellular and Molecular Neurobiology.

[80]  D. Dumont,et al.  A murine model of hereditary hemorrhagic telangiectasia. , 1999, The Journal of clinical investigation.

[81]  C. Betsholtz,et al.  Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. , 1999, Development.

[82]  B. Brooke,et al.  Defective angiogenesis in mice lacking endoglin. , 1999, Science.

[83]  B. Chen,et al.  Distinct roles for the small GTPases Cdc42 and Rho in endothelial responses to shear stress. , 1999, The Journal of clinical investigation.

[84]  K. Hirschi,et al.  PDGF, TGF-β, and Heterotypic Cell–Cell Interactions Mediate Endothelial Cell–induced Recruitment of 10T1/2 Cells and Their Differentiation to a Smooth Muscle Fate , 1998, The Journal of cell biology.

[85]  H. Ellis stroke , 1997, The Lancet.

[86]  R F Spetzler,et al.  The natural history of familial cavernous malformations: results of an ongoing study. , 1994, Journal of neurosurgery.

[87]  H. Bauer,et al.  Neovascularization and the appearance of morphological characteristics of the blood-brain barrier in the embryonic mouse central nervous system. , 1993, Brain research. Developmental brain research.

[88]  John R. Robinson,et al.  Natural history of the cavernous angioma. , 1991, Journal of neurosurgery.

[89]  B. Jacobson,et al.  Ultrastructure and three-dimensional organization of the telangiectases of hereditary hemorrhagic telangiectasia. , 1990, The Journal of investigative dermatology.

[90]  W. Greenough,et al.  Learning causes synaptogenesis, whereas motor activity causes angiogenesis, in cerebellar cortex of adult rats. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[91]  S. Papson,et al.  “Model” , 1981 .

[92]  Marie-José Goumans,et al.  TGF-β signaling in vascular biology and dysfunction , 2009, Cell Research.

[93]  Pui-Yan Kwok,et al.  Tumor necrosis factor-alpha-238G>A promoter polymorphism is associated with increased risk of new hemorrhage in the natural course of patients with brain arteriovenous malformations. , 2006, Stroke.

[94]  H. Arthur,et al.  Endoglin expression in early development is associated with vasculogenesis and angiogenesis , 2002, Mechanisms of Development.

[95]  H. Mennel [Mechanisms of angiogenesis in the brain]. , 2000, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[96]  M. Hadley,et al.  Cavernous malformations and capillary telangiectasia: a spectrum within a single pathological entity. , 1991, Neurosurgery.

[97]  Ryuichi Tanaka,et al.  Angiographic follow-up study of cerebral arteriovenous malformations with reference to their enlargement and regression. , 1989, Neurosurgery.

[98]  D. Eidelman,et al.  Downloaded from http://circres.ahajournals.org / by guest on February 23, 2013A Role for Endoglin in Coupling eNOS Activity and Regulating Vascular Tone Revealed in Hereditary , 2022 .